ARCHIVES

Edelson To Step Down As Yale Center Director.

This article is from The Cancer Letter archive.

Vol. 34 No. 01 | January 11, 2008

Download PDF Visit The Full Archive

Related Articles

DCAB Board Okays One Contract Concept, Sends Another Back to Drawing Board

May 22, 1981

Interest Picks Up In SBIR, NCI May Not Gave To Face Choice of Giving Money Back Or Paying to 500 Level

November 23, 1984

FDA advisors vote against recommending Johnson & Johnson’s Zarnestra for treatment of AML in the elderly.

May 6, 2005

“Projects For Special Donors” – ACS Considering Way To Raise Vast New Sums For Cancer Program

March 31, 1978

Obey Attacks NCI, Eppley, Shubick, Asks for Full Report From GAO

June 10, 1977

FDA Expands Gleevec Indication For Children with Ph+ ALL

January 25, 2013